Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Reviews. Rheumatology|August 19, 2015
Cardiovascular comorbidity in rheumatic diseasesMichael T Nurmohamed, Maaike Heslinga, George D Kitas
Clinical and Experimental Rheumatology|June 6, 2023
Cardiovascular risk management in gout patients: do patients benefit from screening in secondary care?Daisy Vedder, Maaike Heslinga, Carla A Wijbrandts, et al.
The Journal of Rheumatology|June 3, 2017
The Effects of 5-year Etanercept Therapy on Cardiovascular Risk Factors in Patients with Psoriatic ArthritisRabia Agca, Maaike Heslinga, Eva L Kneepkens, et al.
Rheumatology (Oxford, England)|January 19, 2020
Amplified prevalence and incidence of cardiovascular disease in patients with inflammatory arthritis and coexistent autoimmune disordersMaaike Heslinga, Mark M J Nielen, Yvo Smulders, et al.
Rheumatology (Oxford, England)|November 3, 2016
Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosusMichel W P Tsang-A-Sjoe, Irene E M Bultink, Maaike Heslinga, et al.
Nutrients|December 11, 2019
Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic ReviewDaisy Vedder, Wendy Walrabenstein, Maaike Heslinga, et al.
Rheumatology (Oxford, England)|December 6, 2018
The relationship between remission and health-related quality of life in a cohort of SLE patientsMichel W P Tsang-A-Sjoe, Irene E M Bultink, Maaike Heslinga, et al.
The Journal of Rheumatology|February 15, 2025
Cardiometabolic Effects of Apremilast in Patients With Psoriatic Arthritis: A Prospective Cohort StudyRomy Hansildaar, Eva H van Geel, Fatih Çoban, et al.
Rheumatology (Oxford, England)|February 16, 2017
Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis projectInge A M van den Oever, Maaike Heslinga, Ed N Griep, et al.
Pageof 1